We were unable to update this podcast for some time now. As a result, the information shown here might be outdated. If you are the owner of the podcast, you can validate that your RSS feed is available and correct.
It looks like this podcast has ended some time ago. This means that no new episodes have been added some time ago. If you're the host of this podcast, you can check whether your RSS file is reachable for podcast clients.
Pharma Marketing Talk
by ArchiveInterviews of leaders and innovators in pharmaceutical marketing.
Copyright: Copyright Archive
Episodes
Pharma 3D
19m · PublishedTopics for Discussion/Questions:
Give us an short introduction to the e-book Pharma 3D. Why was this written now? Who collaborated in writing the book? What are the major takeaways for pharma?Explain why you think pharma is not doing enough in digital marketing Is it fair to compare pharma to other, more lightly regulated in terms of marketing, industries?The How-to section is extensive. What are the 3 Ds that pharma markets must know?What are your future plans for the book? Are you hoping to include more pharma-specific case studies?
UCB's State ScoreCards
17m · PublishedWhat are ‘The Report Cards’ (aka ScoreCards)?
It is an interesting initiative to lobby decision makers for better access to innovative treatments for Epilepsy. The Record Cards ups the pressure on under-performing state health networks, by increasing transparency on state performance.
Why did they win?
eyeforpharma judges were impressed by the way UCB managed to execute on a strategy to empower others to advocate for better care. It is a well-known truth that pharma is often perceived unwelcome in negotiations for access to innovative medicines. It is a reality of the industry business model that pharma has to battle to overcome access decision makers distrust of increased expenditure on new products.
UCB opened up the data on specialty care and newer anti-epileptic therapies and collaborated to issue independently peer-reviewed literature documenting the health benefits of a comprehensive up-to-date approach to manage this condition.
They then worked with local advocacy groups to share this knowledge along with transparent evaluations tracking the individual state performance on health outcomes. Armed with this information, patients were given the tools to challenge under-performing institutions and demand patient-centric change.
Hacking Healthcare
17m · PublishedCross-Cultural Marketing: Reaching U.S. Hispanics via TV and Mobile Devices
15m · PublishedTelemundo was the media partner and produced "Bajo El Mismo Cielo"First-ever collaboration on a telenovela between pharma and Spanish media360 campaign that included a strong web-presence on Telemundo.com The character in the telenovela discussed type 2 diabetes in on-line vignettesEverything directed back to the campaign websiteCampaign also had a CRM componentCampaign won 7 awards ta DTC Multicultural Health Oct. 2015
Effectiveness of Pharma DTC Advertising
31m · PublishedPharma Marketing Talk has 5 episodes in total of non- explicit content. Total playtime is 1:41:03. The language of the podcast is English. This podcast has been added on October 26th 2022. It might contain more episodes than the ones shown here. It was last updated on March 7th, 2023 13:12.